Gao Hanlin 4

What Happened
Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), had a total of 8,325 shares withheld to satisfy tax withholding on vested restricted stock units (RSUs). The withholdings occurred in three transactions: 897 shares on 2026-02-26 at $24.76 ($22,210), 1,018 shares on 2026-03-01 at $15.33 ($15,606), and 6,410 shares on 2026-03-01 at $15.33 ($98,265). These were tax-withholding dispositions (code F), not open-market sales.

Key Details

• Transaction dates and prices:
  • 2026-02-26: 897 shares withheld @ $24.76 = $22,210 (F1)
  • 2026-03-01: 1,018 shares withheld @ $15.33 = $15,606 (F2)
  • 2026-03-01: 6,410 shares withheld @ $15.33 = $98,265 (F3)
• Total shares withheld: 8,325; total value ≈ $136,081.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Footnotes: F1/F2/F3 indicate shares were withheld to satisfy tax withholding on RSUs granted on 2/26/2024, 2/28/2022, and 2/25/2025 respectively (original grants reported on prior Form 4s).
• Filing: Report filed 2026-03-02 (appears timely based on the reported transaction dates).
• Transaction code: F = shares withheld for tax withholding (routine, not a voluntary market sale).

Context
These transactions represent cashless tax-withholding related to RSU vesting, a common administrative step that results in shares being withheld rather than sold on the open market by choice. Such withholdings generally do not indicate the insider’s view on the company’s prospects.